Bee YS - Search Results

1

Nanocarriers for treatment of ocular neovascularization in the back of the eye: new vehicles for ophthalmic drug delivery.

Shen HH, Chan EC, Lee JH, Bee YS, Lin TW, Dusting GJ, Liu GS. Shen HH, et al. Among authors: bee ys. Nanomedicine (Lond). 2015;10(13):2093-107. doi: 10.2217/nnm.15.47. Epub 2015 Jun 22. Nanomedicine (Lond). 2015. PMID: 26096379 Review.

2

Inhibition of choroidal neovascularization by topical application of angiogenesis inhibitor vasostatin.

Sheu SJ, Bee YS, Ma YL, Liu GS, Lin HC, Yeh TL, Liou JC, Tai MH. Sheu SJ, et al. Among authors: bee ys. Mol Vis. 2009 Sep 18;15:1897-905. Mol Vis. 2009. PMID: 19768130 Free PMC article.

3

Gene Delivery by Subconjunctival Injection of Adenovirus in Rats: A Study of Local Distribution, Transgene Duration and Safety.

Liu GS, Wang JH, Lee JH, Tsai PJ, Tsai HE, Sheu SJ, Lin HC, Dusting GJ, Tai MH, Bee YS. Liu GS, et al. Among authors: bee ys. PLoS One. 2015 Dec 7;10(12):e0143956. doi: 10.1371/journal.pone.0143956. eCollection 2015. PLoS One. 2015. PMID: 26642208 Free PMC article.

4

Gene Delivery of Calreticulin Anti-Angiogenic Domain Attenuates the Development of Choroidal Neovascularization in Rats.

Bee YS, Tu L, Sheu SJ, Lin HC, Tang JH, Wang JH, Prea SM, Dusting GJ, Wu DC, Zhong J, Bui BV, Tai MH, Liu GS. Bee YS, et al. Hum Gene Ther. 2017 May;28(5):403-414. doi: 10.1089/hum.2016.035. Hum Gene Ther. 2017. PMID: 28363247

5

AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization.

Tu L, Wang JH, Barathi VA, Prea SM, He Z, Lee JH, Bender J, King AE, Logan GJ, Alexander IE, Bee YS, Tai MH, Dusting GJ, Bui BV, Zhong J, Liu GS. Tu L, et al. Among authors: bee ys. Angiogenesis. 2018 Feb;21(1):95-109. doi: 10.1007/s10456-017-9591-4. Epub 2018 Jan 9. Angiogenesis. 2018. PMID: 29318471

6

Inhibition of Experimental Choroidal Neovascularization by a Novel Peptide Derived from Calreticulin Anti-Angiogenic Domain.

Bee YS, Ma YL, Chen J, Tsai PJ, Sheu SJ, Lin HC, Huang H, Liu GS, Tai MH. Bee YS, et al. Int J Mol Sci. 2018 Sep 30;19(10):2993. doi: 10.3390/ijms19102993. Int J Mol Sci. 2018. PMID: 30274378 Free PMC article.

7

Topical application of recombinant calreticulin peptide, vasostatin 48, alleviates laser-induced choroidal neovascularization in rats.

Bee YS, Sheu SJ, Ma YL, Lin HC, Weng WT, Kuo HM, Hsu HC, Tang CH, Liou JC, Tai MH. Bee YS, et al. Mol Vis. 2010 Apr 28;16:756-67. Mol Vis. 2010. PMID: 20454694 Free PMC article.

8

Suppression of choroidal neovascularization by intramuscular polymer-based gene delivery of vasostatin.

Sheu SJ, Chou LC, Bee YS, Chen JF, Lin HC, Lin PR, Lam HC, Tai MH. Sheu SJ, et al. Among authors: bee ys. Exp Eye Res. 2005 Dec;81(6):673-9. doi: 10.1016/j.exer.2005.04.005. Epub 2005 Jun 20. Exp Eye Res. 2005. PMID: 15967435

9

Ocular sparganosis mimicking an orbital idiopathic inflammatory syndrome.

Ho TH, Lin MC, Yu WW, Lai PH, Sheu SJ, Bee YS. Ho TH, et al. Among authors: bee ys. Orbit. 2013 Dec;32(6):395-8. doi: 10.3109/01676830.2013.833253. Orbit. 2013. PMID: 24215169

10

Ocular adnexal lymphoma: Five case reports and a literature review.

Tsen CL, Lin MC, Bee YS, Chen JL, Kuo NW, Sheu SJ. Tsen CL, et al. Among authors: bee ys. Taiwan J Ophthalmol. 2015 Apr-Jun;5(2):99-102. doi: 10.1016/j.tjo.2014.05.007. Epub 2014 Aug 1. Taiwan J Ophthalmol. 2015. PMID: 29018677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters